Summary
Samenvatting Neurokinesitherapie 2 theorie sv
- Course
- Institution
SV van de theorie buiten parkinson en dwarsleasie
[Show more]
Seller
Follow
kaatecran1
Content preview
Neurokinesitherapie 2: VolwassenenInhoud
Inleiding
1. Neurologische revalidatie................................................................................................................ 7
1.1 Conceptual framework ............................................................................................................ 8
1.2 Neurologische stoornissen ...................................................................................................... 8
Upper and lower motor neuron lesions .......................................................................................... 9
Zwakte ........................................................................................................................................... 10
Hypertonus / spastische patronen ................................................................................................ 11
Beroerte / CVA............................................................................................................................... 12
1.3 Principes/richtlijnen voor neurologische revalidatie ........................................................... 15
Principe 1: ICF ................................................................................................................................ 15
Principe 2: teamwerk .................................................................................................................... 15
Principe 3: Persoon - gecentreerde zorg ....................................................................................... 16
Principe 4: Voorspelling ................................................................................................................. 18
Principe 5: Neurale plasticiteit ...................................................................................................... 19
Principe 6: Motorische controle – A systems model..................................................................... 21
Principe 7: Functionele bewegingsherstel .................................................................................... 22
Principe 8: Vaardigheidsverwerving .............................................................................................. 23
Principe 9: Zelf-management (Self-Efficacy) ................................................................................. 25
Principe 10: Gezondheid promoten .............................................................................................. 26
1.4 Voorwaarden voor een efficiënte revalidatie ....................................................................... 28
1.5 Veelvoorkomende beperkingen en de impact op de activiteit ............................................. 28
Zwakte ........................................................................................................................................... 29
1
, Vermoeidheid ................................................................................................................................ 30
Stoornissen van spiertonus ........................................................................................................... 31
Stoornissen van coördinatie ......................................................................................................... 35
Stoornissen in motorische planning .............................................................................................. 36
Visuospatiale stoornissen .............................................................................................................. 38
Sensorische stoornissen ................................................................................................................ 40
Secundaire complicaties ................................................................................................................ 41
2. Beroerte / CVA............................................................................................................................... 42
2.1 Introductie ............................................................................................................................. 42
2.2 Epidemiologie ........................................................................................................................ 42
2.3 Pathofysiologie ...................................................................................................................... 43
Cirkel van willis .............................................................................................................................. 43
TOAST: trial of org 10172 in acute stroke treatment .................................................................... 43
Penumbra ...................................................................................................................................... 43
Hersenregio’s................................................................................................................................. 44
Hemisferen .................................................................................................................................... 44
2.3 Diagnose ................................................................................................................................ 46
Secundaire preventie .................................................................................................................... 46
Alarmsymptomen .......................................................................................................................... 47
2.4 Medisch management ........................................................................................................... 47
Ischemische beroerte .................................................................................................................... 47
Hemorragie beroerte..................................................................................................................... 47
2.5 Setting.................................................................................................................................... 48
2.6 Klinische representatie .......................................................................................................... 49
The Oxford Community Stroke Project Classification ................................................................... 49
2
, 2.7 Assessment / beoordeling ..................................................................................................... 50
2.8 Fases ...................................................................................................................................... 52
Hyperacute fase............................................................................................................................. 52
Revalidatiefase .............................................................................................................................. 52
Chronische fase ............................................................................................................................. 53
2.9 Prognose en tijdsverloop herstel .......................................................................................... 54
2.10 Interventies ........................................................................................................................... 55
Algemene beheers problemen ...................................................................................................... 55
Secundaire complicaties vermijden .............................................................................................. 55
2.11 Algemene therapie principes ................................................................................................ 56
Kenmerken van effectieve motorrevalidatie-interventies zijn: .................................................... 56
Algemene aanbevelingen .............................................................................................................. 56
Onderste ledenmaten en locomotorisch herstel: evenwichtstraining ......................................... 57
Gangtraining .................................................................................................................................. 57
Circuit class training ...................................................................................................................... 58
Elektrostimulatie van paretisch OL ............................................................................................... 59
Elektrostimulatie van paretische arm en hand ............................................................................. 59
Herstel bovenste lidmaat .............................................................................................................. 59
Virtuele realiteit ............................................................................................................................ 60
Robot geassisteerde therapie voor bovenste lidmaat .................................................................. 61
Therapie levering ........................................................................................................................... 61
Besluit ............................................................................................................................................ 62
Multiple Sclerose
1. Pathofysiologie .............................................................................................................................. 63
Proces ............................................................................................................................................ 64
3
, 2.1 Typen van MS ........................................................................................................................ 65
2.2 Diagnose ................................................................................................................................ 67
2. Symptomen ................................................................................................................................... 67
2.1 Mentaal ................................................................................................................................. 68
Vermoeidheid ................................................................................................................................ 68
2.2 Neuromuskuloskeletaal ......................................................................................................... 70
Hypertonie en spasticiteit ............................................................................................................. 70
Hypotonie en spierzwakte ............................................................................................................. 70
Ataxie ............................................................................................................................................. 70
2.3 Cardiovasculair ...................................................................................................................... 71
Aerobe capaciteit .......................................................................................................................... 71
3. Klinisch management .................................................................................................................... 72
3.1 Oefentherapie ....................................................................................................................... 72
Veiligheid ....................................................................................................................................... 72
Effectiviteit .................................................................................................................................... 72
Lichaamsfuncties ........................................................................................................................... 73
Actief ............................................................................................................................................. 73
3.2 Levensveranderingen ............................................................................................................ 74
Coping strategieën ........................................................................................................................ 74
Recreatie en vrijetijdsbesteding .................................................................................................... 74
3.3 Conclusie ............................................................................................................................... 74
Pusher-Syndroom
1. Definitie ......................................................................................................................................... 75
2. Kenmerken .................................................................................................................................... 75
2.1 Liggen .................................................................................................................................... 75
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller kaatecran1. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $5.93. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
56326 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now